Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
Rank in Stocks
#800
Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.... Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. specializes in providing a comprehensive range of medical devices and innovative healthcare solutions. Its extensive portfolio encompasses several key segments. Within patient monitoring and life support, the company manufactures crucial equipment such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, and endoscopes, along with associated accessories. This segment also delivers integrated solutions for emergency care, peri-operative management, critical care, and medical IT systems. For in-vitro diagnostics, Mindray offers sophisticated products including hematology and chemistry analyzers and their reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry instruments, and microplate readers and washers. These are further supported by solutions tailored for coagulation, urinalysis, and microbiology. The company additionally produces advanced medical imaging systems, covering both ultrasound and radiology products, and supplies a dedicated line of veterinary products. Founded in 1991, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. maintains its primary operational base in Shenzhen, People's Republic of China.
Share Price
$24.98
Market Cap
$30.28B
Change (1 day)
1.56%
Change (1 year)
-20.41%
Country
CN
Trade Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
Category
Healthcare
P/E ratio for Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
P/E ratio as of October 2026 TTM: 25.73
According to Shenzhen Mindray Bio-Medical Electronics Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 25.73. At the end of 2023 the company had a P/E ratio of 30.70.
P/E ratio history for Shenzhen Mindray Bio-Medical Electronics Co., Ltd. from 2014 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 25.73 | -2.75% |
| 2024 | 26.46 | -13.80% |
| 2023 | 30.70 | -22.85% |
| 2022 | 39.79 | -31.17% |
| 2021 | 57.81 | -25.68% |
| 2020 | 77.79 | 64.65% |
| 2019 | 47.24 | 48.75% |
| 2018 | 31.76 | 7.12% |
| 2017 | 29.65 | -32.07% |
| 2016 | 43.65 | -39.13% |
| 2015 | 71.70 | 50.00% |
| 2014 | 47.80 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 33.11 | 28.67% |
US
|
|
| 21.39 | -16.88% |
IE
|
|
| 28.94 | 12.48% |
US
|
|
| 17.34 | -32.62% |
US
|
|
| - | - |
DE
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.